These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 3382149)

  • 21. International Federation of Clinical Chemistry, Scientific Division Committee on Enzymes: approved recommendation on IFCC methods for the measurement of catalytic concentration of enzymes. Part 7. IFCC method for creatine kinase (ATP: creatine N-phosphotransferase, EC 2.7.3.2).
    Hørder M; Elser RC; Gerhardt W; Mathieu M; Sampson EJ
    Eur J Clin Chem Clin Biochem; 1991 Jul; 29(7):435-56. PubMed ID: 1932364
    [No Abstract]   [Full Text] [Related]  

  • 22. Refolding of SDS- and thermally denatured MM-creatine kinase using cyclodextrins.
    Couthon F; Clottes E; Vial C
    Biochem Biophys Res Commun; 1996 Oct; 227(3):854-60. PubMed ID: 8886021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Creatine kinase activity in cerebrospinal fluid.
    Chandler WL; Clayson KJ; Fine JS; Longstreth WT
    Arch Neurol; 1987 May; 44(5):471-2. PubMed ID: 3579653
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term preservation of the mammalian myocardium. Effect of storage medium and temperature on the vulnerability to tissue injury.
    Takahashi A; Braimbridge MV; Hearse DJ; Chambers DJ
    J Thorac Cardiovasc Surg; 1991 Aug; 102(2):235-45. PubMed ID: 1865698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of the role of reactive cystein in arginine kinase: reactivation kinetics of 5,5'-dithiobis-(2-nitrobenzoic acid)-modified arginine kinase reactivated by dithiothreitol.
    Pan JC; Cheng Y; Hui EF; Zhou HM
    Biochem Biophys Res Commun; 2004 Apr; 317(2):539-44. PubMed ID: 15063791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The use of primate tissue homogenates for quality control in the creatine kinase-MB determination with inhibiting antibodies (author's transl)].
    Neumeier D; Siegele B; Glück B; Knedel M
    J Clin Chem Clin Biochem; 1977 May; 15(5):289-91. PubMed ID: 408459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative enzymologic analysis of the creatine kinases from the skeletal muscles of the cod, frog and rabbit].
    Petrova TA; Shamova OV; Lyzlova SN
    Zh Evol Biokhim Fiziol; 1988; 24(4):489-96. PubMed ID: 3206952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Standard method for the determination of creatine kinase activity].
    J Clin Chem Clin Biochem; 1977 Apr; 15(4):249-60. PubMed ID: 16981
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of brain creatine kinase activity after renal ischemia is attenuated by N-acetylcysteine and deferoxamine administration.
    Di-Pietro PB; Dias ML; Scaini G; Burigo M; Constantino L; Machado RA; Dal-Pizzol F; Streck EL
    Neurosci Lett; 2008 Mar; 434(1):139-43. PubMed ID: 18304734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-acetylcysteine decreases angiotensin II receptor binding in vascular smooth muscle cells.
    Ullian ME; Gelasco AK; Fitzgibbon WR; Beck CN; Morinelli TA
    J Am Soc Nephrol; 2005 Aug; 16(8):2346-53. PubMed ID: 15944340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrogen peroxide targets the cysteine at the active site and irreversibly inactivates creatine kinase.
    Li C; Sun S; Park D; Jeong HO; Chung HY; Liu XX; Zhou HM
    Int J Biol Macromol; 2011 Dec; 49(5):910-6. PubMed ID: 21854802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Negative interference of N-acetyl cysteine (NAC) on selected chemistries on the Abbott architect platform.
    Agbor TA; Brown M; Clark L; Kavsak PA
    Clin Chim Acta; 2015 Dec; 451(Pt B):219-21. PubMed ID: 26434549
    [No Abstract]   [Full Text] [Related]  

  • 33. Certification of the mass concentration of creatine kinase isoenzyme 2 (CK-MB) in the reference material BCR 608.
    Sánchez M; Gella FJ; Profilis C; Ceriotti F; Cusó E; Fuentes-Arderiu X; Hallermayer K; Hørder M; Panteghini M; Schumann G; Canalias F
    Clin Chem Lab Med; 2001 Sep; 39(9):858-65. PubMed ID: 11601686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bretschneider's histidine-buffered cardioplegic solution and the calcium paradox.
    Ruigrok TJ; de Moes D; Borst C
    J Thorac Cardiovasc Surg; 1983 Sep; 86(3):412-7. PubMed ID: 6887957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of "clear" enzyme control materials.
    Hardin E; Passey R; Gillum RL; Fuller JB; Gant D
    Am J Med Technol; 1979 Mar; 45(3):183-5. PubMed ID: 425991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactivation of creatine kinase activity by preincubation with buffered NAC diluent.
    Penny AF; Jennings A
    Ann Clin Biochem; 1988 Mar; 25 ( Pt 2)():181-5. PubMed ID: 3382149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-Acetyl-L-cysteine as a reactivator of creatine kinase.
    Nealon DA; Henderson AR
    Clin Chem; 1977 Mar; 23(3):618. PubMed ID: 13948
    [No Abstract]   [Full Text] [Related]  

  • 38. False results with the N-acetylcysteine-activated, immunoinhibited CK-MB determination.
    Mall T; Grossenbacher M; Scholer A
    Clin Chem; 1985 Dec; 31(12):2040. PubMed ID: 4064296
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of diluent temperature on creatine kinase values found for lyophilized controls and reference sera.
    Feld RD; Brown LF; Neri BP; Witte DL
    Clin Chem; 1978 Nov; 24(11):2039-41. PubMed ID: 101318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactivation of creatine kinase by dithiothreitol prior to use in an in vitro translation extract.
    Favre D; Muellhaupt B
    ALTEX; 2005; 22(4):259-64. PubMed ID: 16344908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.